Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01087281 · ClinicalTrials.gov registry record

Top-Down Attentional Control of Visual-Processing

A clinical trial of fMRI and Focal Brain Lesion, sponsored by National Institute of Mental Health (NIMH).

Recruiting
Registry status
300
Enrollment target
1
Study location

NCT01087281 is a study of fMRI and Focal Brain Lesion that is actively recruiting participants, run by National Institute of Mental Health (NIMH). The registered enrollment target is 300 participants, below the 385-participant average among 6 other fMRI trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01087281, a study of fMRI and Focal Brain Lesion, is actively recruiting participants, sponsored by National Institute of Mental Health (NIMH).

RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

Background: \- Previous studies have shown that people with certain types of brain damage may have particular problems paying attention and processing things that they see. Researchers are interested in comparing how people with brain damage and without brain damage process visual images. Objectives: \- To better understand the areas of the brain involved in paying attention to things that are seen. Eligibility: \- Individuals at least 18 years of age who either have had damage to one or both sides of specific parts of the brain (e.g., stroke, injury, certain neurosurgery procedures) or are healthy volunteers. Design: * The study involves 4 to 10 visits to the NIH Clinical Center over 1 to 2 years. Each visit will last approximately 2 hours. * Participants will be screened with a medical history and physical examination, and may have the cognitive testing described below during the same visit. * On the first visit and for at least one visit thereafter, participants will have cognitive testing to evaluate thinking and memory. These tests will be either written tests or computer-based tests. * Some participants will qualify for functional magnetic resonance imaging (fMRI) as part of the study. This part will involve a decision-making task that will be performed on a computer during the fMRI scan. Additional scans may be required as directed by the study doctors. * Some randomly selected participants will be asked to have magnetoencephalography (MEG), a procedure to record very small magnetic field changes produced by brain activity. * During the behavioral training, or fMRI or MEG scanning, participants may be monitored with equipment to track eye movements.

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2012-07-23

What the Registry Record Tells You About NCT01087281

The ClinicalTrials.gov registry entry for NCT01087281 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 385-participant average among 6 other fMRI trials with a reported enrollment target (22% lower). The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with fMRI appearing as the primary indexed condition, and to 0 interventions.

NCT01087281 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01087281 about?

NCT01087281 is a clinical study titled "Top-Down Attentional Control of Visual-Processing". Background: \- Previous studies have shown that people with certain types of brain damage may have particular problems paying attention and processing things that they see. Researchers are interested in comparing how people with brain damage and without brain damage process visual images. Objectiv...

What is the current status of trial NCT01087281?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2012-07-23.

What conditions does trial NCT01087281 study?

This clinical trial studies the following conditions: fMRI, Focal Brain Lesion, Focal Lesions.

Who is sponsoring clinical trial NCT01087281?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01087281 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for fMRI

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.